Scientific Program Presentations

Updated: 31 May, 2007

Please note that only current ISPD members have access to the posted presentations, via a password provided only to members. Presentations are in PDF format, with editing and printing disabled.

See the Membership Information page to apply for and learn about the other benefits of ISPD membership.

Check this page for updates regularly. If you were a Conference speaker and would like to share your presentation with ISPD members, please send your file to ISPD Headquarters via e-mail at info@ispdhome.org.

GENERAL BUSINESS MEETING*
Report to Membership (President's, Treasurer's and Headquarters' Reports)
14th International Conference, 1 - 5 June 2008 in Vancouver, Canada
*The General Business Meeting presentations are available for viewing by both ISPD members and nonmembers.
 

1. D'Alton M.  Main result of FASTER. Presentation not available at this time.
2. Wald N.  Advances from SURUSS and FASTER. Presentation will not be posted.
3. Wright D.  Improving integrated screening with repeated measurements of the same marker. Presentation not available at this time.
4. Canick J.  Screening policy: recent advances worth implementing. Presentation not available at this time.

Plenary Session 2
ULTRASOUND FOR ANEUPLOIDY (ll)
Chairpersons: Antonioni Burrell (Spain), Ritsuko Pooh (Japan)

1. Cicero S.  Absent of hypoplastic nasal bone as a screening marker. Did not attend.
2. Borrell A.  Ductus venosus flow as a fetal aneuploidy marker.
3. Smith-Bindman R.  Second trimester prenatal ultrasound for the detection of fetuses with Down’s syndrome. Presentation not available at this time.
4. Norgaad-Pederson B.  ADAM 12 and other potential new serum markers. Presentation will not be posted.

Plenary Session 3
PRENATAL DIAGNOSIS AND THERAPY OF FETAL INFECTION
Chairpersons: Umberto Nicolini (Italy), Daniel Surbeck (Switzerland)

1. Tanemura M.  Maternal risk factors for the development of congenital rubella syndrome. Presentation not available at this time.
2. Morishima T.  Quantitative analysis of virus load and virus-specific CTL in Cytomegalic inclusion disease. Presentation not available at this time.
3. Surbek D.  Prevention of vertical transmission of AIDS during pregnancy: current evidence. Presentation not available at this time.
4. Nicolini U.  Markers of fetal infection and damage with maternal CMV infection.

Plenary Session 4
ETHICAL AND LEGAL ISSUES IN PRENATAL DIAGNOSIS
Chairpersons: Eugene Pergament (UK), Michael Katz (US)

1. Liebaers I.  Legal and ethical issues in preimplantation genetic diagnosis. Presentation not provided at this time.
2. Marteau T.  Informed choice in prenatal diagnosis: rhetoric or reality? Did not attend.
3. Pergament E.  Prenatal paradigms and paradoxes. Presentation not available at this time.
4. Shulman L.  Ethical considerations in prenatal diagnosis: the critical roles of patient and clinician demography

Plenary Session 5
ULTRASOUND AND OTHER IMAGING TECHNOLOGIES FOR STRUCTURAL FETAL ANOMALIES
Chairpersons: Israel Meizner (Israel), Jin-Chung Shih (Taiwan)

1. Pooh RK.  Prenatal imaging diagnosis of central nervous system. Presentation not available at this time.
2. Shih J-C.  4D STIC (spatiotemporal imaging correction) imaging illustrates unique and independent clues for diagnosing complex structural cardiac diseases of fetus. Presentation not available at this time.
3. Meizner I.  Fetal genital abnormalities: the role of ultrasound diagnosis. Presentation not available at this time.
4. Prayer D.  Prenatal diagnostics using Magnetic Resonance Imaging. Presentation not available at this time.

Plenary Session 6
IN UTERO MANAGEMENT OF THE FETUS WITH BIRTH DEFECT
Chairpersons: Mark Evans (US), Mami Yamasaki (Japan)

1. Sepulveda W.  Fetal hydrothorax: prenatal assessment and management. Did not attend.
2. Yamasaki M.  In utero management of fetal hydrocephalus. Presentation not available at this time.
3. Murotsuki J.  Ultrasonographic findings of skeletal dysplasia with a poor outcome. Presentation not available at this time.
4. Evans M.  Management of anomalies and selective termination. Presentation not available at this time.

Plenary Session 7
CURRENT STATUS OF FETAL THERAPY
Chairpersons: Charles Rodeck (UK), Jan Deprest (Belgium)

1. Rodeck C.  Development of gene therapy. Presentation not available at this time.
2. Deprest J.  Fetoscopic endoluminal tracheal occlusion for severe congenital diaphragmatic hernia. Presentation will not be posted.
3. Wilson D.  Maternal fetal surgery for myelomeningocele: benefits and risks for fetus and mother. Presentation not available at this time.
4. Sago H.  The current status of fetal surgery in Japan. Presentation not available at this time.

Plenary Session 8
MINIMALLY INVASIVE FETAL THERAPY
Chairpersons: Waldo Sepulveda (UK), Takeshi Murakoshi (Japan)

1. Deprest J.  Selective feticide in complicated monozygotic twins. Presentation will not be posted.
2. Sepulveda W.  Management of acardiac twinning. Did not attend.
3. Murakoshi T.  Fetoscopic laser photocoagulation of communicating vessels for twin-twin transfusion syndrome: Japanese 3 years' experiences. Presentation not available at this time.
4. Fisk N.  Management paradigms for TTTS post-Eurofetus: Is there a role for alternative therapies? Presentation not available at this time.

Plenary Session 9
NEW TECHNOLOGIES IN ASSISTED REPRODUCTION
Chairpersons: Henry Malter (US), Yasunori Yoshimura (Japan)

1. Malter H.  ART and science: controversies and prospects. Presentation not available at this time.
2. Palermo G.  Attempts in conditioning and manufacturing gamete. Presentation not available at this time.
3. Kono N.  Regulation of mammalian development by genomic imprinting. Presentation not available at this time.
4. Eggan K.  Cloning and stem cells: epigenetic reprogramming after nuclear transplantation and cell fusion. Did not attend.

Plenary Session 10
PGD (EXAMINING CHROMOSOMES)
Chairpersons: Santiago Munne (US), Joyce Harper (UK)

1. Harper J.  Current status of PGD. Presentation not available at this time.
2. Magli C.  PGD for patients carrying chromosome abnormalities. Presentation not available at this time.
3. Munne S.  Aneuploidy screening. Presentation not available at this time.
4. Wilton L.  The use of CGH and microarray for aneuploidy screening. Presentation not available at this time.

Plenary Session 11
PGD (EXAMINING GENES)
Chairpersons: Yury Verlinsky (US), Karen Sermon (Belgium)

1. Sermon K.  PGD for monogenic diseases.
2. Verlinsky Y.  Expanding indications for PGD. Presentation not available at this time.
3. Rechitsky S.  PGD for novel indications such as HLA. Presentation not available at this time.
4. Ogilvie C.  Pleimplantation genetic haprotyping (PGH): a generic approach to PGD for any mapped single gene disorder. Presentation not available at this time.

Plenary Session 12
PGD IN ASIA
Chairpersons: Inn Soo Kang (Korea), Harumi Kubo (Japan)

1. Katagiri Y.  PGD and embryo selection for ART in Japan. Presentation not available at this time.
2. Kim J-Y.  PGD in reproductive failure and genetic disease. Presentation not available at this time.
3. Chen C-K.  Experience of PGD in Taiwan. Presentation not available at this time.
4. Kim C-H.  PGD for aneuploidy screening in Korea. Presentation not available at this time.
5. Tanaka A.  The efficacy of preimplantation genetic screening in assisted reproductive technology (IVF). Presentation not available at this time.

Plenary Session 13
FETAL DNA/RNA IN MATERNAL BLOOD AND BODY FLUIDS
Chairpersons: Dennis Lo (China), Akihiko Sekizawa (Japan)

1. Lo D.  Recent advances in fetal nucleic acids in maternal plasma. Presentation will not be posted.
2. Oudejans C.  Chromosome 21-specific mRNA in maternal plasma. Presentation will not be posted.
3. Farina A.  Circulating placental RNA as a possible tool for early detection of pregnancy-associated disorders. Presentation not available at this time.
4. Holzgreve W.  In vitro generation of syncytiotrophoblast: a model system for studying the effect of fetal material in the maternal circulation and fetal RNA in preeclampsia. Did not attend.
5. Bianchi D.  Fetal RNA profiling: implication for prenatal monitoring.Presentation not available at this time.

Plenary Session 14
FETAL STEM CELLS IN THE MOTHER
Chairpersons: Diana Bianchi (US), Hiromitsu Nakauchi (Japan)

1. Nakauchi H.  Stem cells in prenatal diagnosis and perinatal medicine. Presentation not available at this time.
2. Fisk N.  Fetal mesenchymal stem cells. Presentation not available at this time.
3. Bianchi D.  Pregnancy-associated progenitor cells. Presentation not available at this time.
4. Surbeck D.  Cord blood and placenta as a source of stem cells for fetus and mother. Presentation not available at this time.

Plenary Session 15
INVASIVE PRENATAL DIAGNOSIS
Chairpersons: Albert Fortuny (Spain), Enrique Gadow (Argentina)

1. Borrell A.  Invasive testing with different aneuploidy screening strategy. Presentation not available at this time.
2. Brambati B.  Management of multiple pregnancy: fetal reduction and prenatal diagnosis. Presentation not available at this time.
3. Otano L.  What are the risk figures for counseling today?
4. Wapner R.  Invasive diagnosis in twins and higher-older pregnancies. Presentation not available at this time.
5. Chakravsky A.  Prenatal diagnosis of genetic disorders - multicentric Indian data. Presentation not available at this time.

Plenary Session 16
NEW TECHNOLOGIES FOR PRENTAL DIAGNOSIS
Chairpersons: Hiroshi Shimizu (Japan), Eric Jauniaux (UK)

1. Bui T-H.  Role of first-trimester fetoscopy in prenatal diagnosis. Presentation not available at this time.
2. Jauniaux E.  Coelocentesis: Back to the future. Did not attend.
3. Shimizu H.  What's new in prenatal diagnosis of skin diseases? Presentation not available at this time.
4. Yoshimatsu J.  Use of three-dimensional extended imaging software in the study of the fetal anomalies. Presentation not available at this time.
5. Van den Veyver IB.  Array-CGH, a new genetic technology for prenatal diagnosis. Presentation not available at this time.

Plenary Session 17
MOLECULAR CYTOGENETICS (MICROARRAY, CGH AND FISH)
Chairpersons: Malcolm Ferguson-Smith (UK), Lisa Shaffer (US)

1. Bischoff F.  FISH strategies for PGD and non-invasive prenatal testing. Presentation not available at this time.
2. Shaffer L.  The use of array CGH to detect cytogenetic abnormalities. Presentation not available at this time.
3. Wakui K.  Cryptic chromosomal rearrangements overlooked by cytogenetic technique. Presentation not available at this time.
4. Lee C.  Normal imbalances in the human genome detected by array-CGH. Presentation will not be posted.

Plenary Session 18
MOLECULAR CYTOGENETICS (QF-PCR)
Chairpersons: Matteo Adinolfi (UK), Antonio Forabosco (Italy)

1. Cirigliano V.  Large scale prenatal diagnosis by QF-PCR. Results of seven years clinical experience. Presentation not available at this time.
2. Ogilvie C.  Robust and efficient prenatal detection of trisomies by QF-PCR: throughout, interpretation and unusual findings. Presentation not available at this time.
3. Rickman L.  Prenatal diagnosis of aneupoidies by QF-PCR and microarray. Presentation not available at this time.
4. Chen C-P.  Application of the QF-PCR in perinatal investigation of prenatally detected mosaicism and chimerism.

Plenary Session 19
MOLECULAR DIAGNOSIS
Chairpersons: Chairpersons: Joe Leigh Simpson (US), Aubrey Milunsky (US)

1. Milunsky A.  Advances in molecular genetics that impact prenatal diagnosis and perinatal medicine. Presentation not available at this time.
2. Kosaki K.  DHPLC in clinical molecular diagnostic services. Presentation not available at this time.
3. Toda T.  Molecular genetics of Fukuyama-type congenital muscular dystrophy and alpha-dystroglycanopathies. Presentation not available at this time.
4. Shimizu S.  Approach to noninvasive prenatal genetic diagnosis and difficulties. Presentation not available at this time.

Plenary Session 20
IGF/IGFBP SYSTEM IN PREGNANCY
Chairpersons: Eeva-Marja Rutanen (Finland), Mitsutoshi Iwashita (Japan)

1. Ratnum E-M.  Usefulness of IGFBP-1 in PROM diagnosis. Presentation not available at this time.
2. Westwood M.  Multiplicity in regulatory mechanism of IGF action and fetal growth. Presentation not available at this time.
3. Sugawara J.  Hypoxia regulation of human IGFBP-1 gene. Presentation not available at this time.
4. Kabir-Salmani M.  Post-translational regulation of decidual IGFBP-1 and its function. Presentation not available at this time.
5. Kwek KYC.  Usefulness of phosphorylated IGFBP-1 for preterm birth diagnosis. Presentation not available at this time.